These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 20231283)
1. Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization. Alger HM; Brown JM; Sawyer JK; Kelley KL; Shah R; Wilson MD; Willingham MC; Rudel LL J Biol Chem; 2010 May; 285(19):14267-74. PubMed ID: 20231283 [TBL] [Abstract][Full Text] [Related]
2. Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice. Bell TA; Brown JM; Graham MJ; Lemonidis KM; Crooke RM; Rudel LL Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1814-20. PubMed ID: 16675724 [TBL] [Abstract][Full Text] [Related]
3. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice. Bell TA; Kelley K; Wilson MD; Sawyer JK; Rudel LL Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1396-402. PubMed ID: 17431188 [TBL] [Abstract][Full Text] [Related]
4. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss. Brown JM; Bell TA; Alger HM; Sawyer JK; Smith TL; Kelley K; Shah R; Wilson MD; Davis MA; Lee RG; Graham MJ; Crooke RM; Rudel LL J Biol Chem; 2008 Apr; 283(16):10522-34. PubMed ID: 18281279 [TBL] [Abstract][Full Text] [Related]
5. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential. Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318 [TBL] [Abstract][Full Text] [Related]
6. Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice. Willner EL; Tow B; Buhman KK; Wilson M; Sanan DA; Rudel LL; Farese RV Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1262-7. PubMed ID: 12538880 [TBL] [Abstract][Full Text] [Related]
7. Monounsaturated fatty acyl-coenzyme A is predictive of atherosclerosis in human apoB-100 transgenic, LDLr-/- mice. Bell TA; Wilson MD; Kelley K; Sawyer JK; Rudel LL J Lipid Res; 2007 May; 48(5):1122-31. PubMed ID: 17277381 [TBL] [Abstract][Full Text] [Related]
8. Soat2 ties cholesterol metabolism to β-oxidation and glucose tolerance in male mice. Pramfalk C; Ahmed O; Pedrelli M; Minniti ME; Luquet S; Denis RG; Olin M; Härdfeldt J; Vedin LL; Steffensen KR; Rydén M; Hodson L; Eriksson M; Parini P J Intern Med; 2022 Aug; 292(2):296-307. PubMed ID: 34982494 [TBL] [Abstract][Full Text] [Related]
9. Impact of SCP-2/SCP-x gene ablation and dietary cholesterol on hepatic lipid accumulation. Klipsic D; Landrock D; Martin GG; McIntosh AL; Landrock KK; Mackie JT; Schroeder F; Kier AB Am J Physiol Gastrointest Liver Physiol; 2015 Sep; 309(5):G387-99. PubMed ID: 26113298 [TBL] [Abstract][Full Text] [Related]
10. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism. Song H; Zhu L; Picardo CM; Maguire G; Leung V; Connelly PW; Ng DS Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E17-E25. PubMed ID: 16105858 [TBL] [Abstract][Full Text] [Related]
11. ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice. Lee RG; Shah R; Sawyer JK; Hamilton RL; Parks JS; Rudel LL J Lipid Res; 2005 Jun; 46(6):1205-12. PubMed ID: 15805543 [TBL] [Abstract][Full Text] [Related]
12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related]
13. Tissue-specific knockouts of ACAT2 reveal that intestinal depletion is sufficient to prevent diet-induced cholesterol accumulation in the liver and blood. Zhang J; Kelley KL; Marshall SM; Davis MA; Wilson MD; Sawyer JK; Farese RV; Brown JM; Rudel LL J Lipid Res; 2012 Jun; 53(6):1144-52. PubMed ID: 22460046 [TBL] [Abstract][Full Text] [Related]
17. Intestine-specific MTP and global ACAT2 deficiency lowers acute cholesterol absorption with chylomicrons and HDLs. Iqbal J; Boutjdir M; Rudel LL; Hussain MM J Lipid Res; 2014 Nov; 55(11):2261-75. PubMed ID: 25030663 [TBL] [Abstract][Full Text] [Related]
18. An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis. Crooke RM; Graham MJ; Lemonidis KM; Whipple CP; Koo S; Perera RJ J Lipid Res; 2005 May; 46(5):872-84. PubMed ID: 15716585 [TBL] [Abstract][Full Text] [Related]
19. Role of acyl-coenzyme A:cholesterol acyltransferase-1 in the control of hepatic very low density lipoprotein secretion and low density lipoprotein receptor expression in the mouse and hamster. Spady DK; Willard MN; Meidell RS J Biol Chem; 2000 Sep; 275(35):27005-12. PubMed ID: 10869364 [TBL] [Abstract][Full Text] [Related]